Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@BioStocks Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::112872946.png) @BioStocks Bio Stocks™

Bio Stocks™ posts on X about $barcl, $lly, $nvo, $vktx the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::112872946/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::112872946/c:line/m:interactions.svg)

- X Week XXXXXXX -XX%
- X Month XXXXXXX -XX%
- X Months XXXXXXXXX +16%
- X Year XXXXXXXXX +3.30%

### Mentions: XX [#](/creator/twitter::112872946/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::112872946/c:line/m:posts_active.svg)

- X Week XX -XXXX%
- X Month XXX -XXXX%
- X Months XXX +3.30%
- X Year XXXXX +57%

### Followers: XXXXXX [#](/creator/twitter::112872946/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::112872946/c:line/m:followers.svg)

- X Week XXXXXX +0.15%
- X Month XXXXXX +0.77%
- X Months XXXXXX +3.20%
- X Year XXXXXX +5.40%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::112872946/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::112872946/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::112872946/influence)
---

**Social category influence**
[finance](/list/finance)  XXXX% [stocks](/list/stocks)  XXXX% [cryptocurrencies](/list/cryptocurrencies)  XXXX%

**Social topic influence**
[$barcl](/topic/$barcl) #133, [$lly](/topic/$lly) #74, [$nvo](/topic/$nvo) #69, [$vktx](/topic/$vktx) 0.36%, [$absi](/topic/$absi) #4, [$amgn](/topic/$amgn) 0.36%, [$biib](/topic/$biib) #3, [$bcrx](/topic/$bcrx) #7, [$atxs](/topic/$atxs) #9, [$anab](/topic/$anab) XXXX%

**Top accounts mentioned or mentioned by**
[@biopharmiq](/creator/undefined) [@biotechtoast](/creator/undefined) [@dace0325](/creator/undefined) [@thenorthstar5](/creator/undefined) [@bambossie81](/creator/undefined) [@pawcio2009](/creator/undefined) [@a_may_md](/creator/undefined) [@grok](/creator/undefined) [@learnbiotech](/creator/undefined) [@_joebaffoe](/creator/undefined) [@biopharmacaster](/creator/undefined) [@persimmonti](/creator/undefined) [@yaireinhorn](/creator/undefined) [@canuckcapital5](/creator/undefined) [@ikehiefosa](/creator/undefined) [@monaco_biotech](/creator/undefined) [@malibu_rum67](/creator/undefined) [@bluemoontrades](/creator/undefined) [@mmikethe](/creator/undefined) [@oncinvestor](/creator/undefined)

**Top assets mentioned**
[Eli Lilly and Company (LLY)](/topic/$lly) [Novo-Nordisk (NVO)](/topic/$nvo) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Amgen, Inc. (AMGN)](/topic/$amgn) [Biogen Inc (BIIB)](/topic/$biib) [Roivant Sciences Ltd. Common Shares (ROIV)](/topic/$roiv) [Passage (PASG)](/topic/$pasg) [United Therapeutics, Corp. (UTHR)](/topic/united-therapeutics-corp) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Huma Finance (HUMA)](/topic/$huma) [Bitcoin (BTC)](/topic/bitcoin) [iShares BTC Trust (IBIT)](/topic/$ibit) [Grayscale BTC ETF (GBTC)](/topic/$gbtc) [Deutsche Bank Aktiengesellschaft (DB)](/topic/$db) [SPDR GOLD ETF (GLD)](/topic/$gld) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX)](/topic/$rxrx) [GoodRx Holdings, Inc. Class A Common Stock (GDRX)](/topic/$gdrx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Denali Therapeutics Inc. Common Stock (DNLI)](/topic/$dnli) [Morgan Stanley (MS)](/topic/morgan-stanley) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx) [Johnson & Johnson (JNJ)](/topic/$jnj)
### Top Social Posts [#](/creator/twitter::112872946/posts)
---
Top posts by engagements in the last XX hours

"$ANAB Announces Late-Breaking Presentation of Complete Phase 2b Data for Rosnilimab in RA at #ACR25"  
[X Link](https://x.com/BioStocks/status/1977725473690968536) [@BioStocks](/creator/x/BioStocks) 2025-10-13T13:17Z 69.9K followers, 3767 engagements


"$OMER and $NVO announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart. $340M upfront"  
[X Link](https://x.com/BioStocks/status/1978442594939015310) [@BioStocks](/creator/x/BioStocks) 2025-10-15T12:47Z 69.9K followers, 15K engagements


"$ROIV and Priovant Announce Positive Phase X VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)"  
[X Link](https://x.com/BioStocks/status/1968269093494214915) [@BioStocks](/creator/x/BioStocks) 2025-09-17T11:01Z 69.9K followers, 9653 engagements


"$PASG 1-for-20 Reverse Split"  
[X Link](https://x.com/BioStocks/status/1943264531716677964) [@BioStocks](/creator/x/BioStocks) 2025-07-10T11:02Z 69.9K followers, 3138 engagements


"$UTHR TETON-2 Pivotal Study of Tyvaso Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis"  
[X Link](https://x.com/BioStocks/status/1962833092466327855) [@BioStocks](/creator/x/BioStocks) 2025-09-02T11:00Z 69.9K followers, 21.1K engagements


"$SRPT to Present New Data from its Neuromuscular Portfolio at #WMS25"  
[X Link](https://x.com/BioStocks/status/1974089870332334567) [@BioStocks](/creator/x/BioStocks) 2025-10-03T12:31Z 69.9K followers, 8934 engagements


"$CYTK PT raised to $XX at Barclays"  
[X Link](https://x.com/BioStocks/status/1975151672063385831) [@BioStocks](/creator/x/BioStocks) 2025-10-06T10:50Z 69.9K followers, 13.7K engagements


"$GUTS Announces Potent Preclinical Results from RJVA-002 a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity. RJVA-002 achieved XX% weight loss at five weeks in a translational obesity model; weight loss not yet plateaued"  
[X Link](https://x.com/BioStocks/status/1975516891826241765) [@BioStocks](/creator/x/BioStocks) 2025-10-07T11:01Z 69.9K followers, 10.7K engagements


"$HUMA $60M direct offering priced at $2.11"  
[X Link](https://x.com/BioStocks/status/1975547915281310106) [@BioStocks](/creator/x/BioStocks) 2025-10-07T13:05Z 69.9K followers, 4242 engagements


"Both #Bitcoin and Gold to likely feature on central bank balance sheets by 2030 - Deutsche Bank. $BTC $GLD $IBIT $GBTC"  
[X Link](https://x.com/BioStocks/status/1975672229007663358) [@BioStocks](/creator/x/BioStocks) 2025-10-07T21:19Z 69.9K followers, 3705 engagements


"$APGE $300M offering priced @ $41/share"  
[X Link](https://x.com/BioStocks/status/1976105576108085628) [@BioStocks](/creator/x/BioStocks) 2025-10-09T02:00Z 69.9K followers, 14.5K engagements


"$ABVX initiated with an Overweight at Barclays. PT $142"  
[X Link](https://x.com/BioStocks/status/1977675873957679580) [@BioStocks](/creator/x/BioStocks) 2025-10-13T10:00Z 69.9K followers, 6749 engagements


"$RCKT FDA accepts BLA Resubmission of KRESLADI for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) PDUFA 03/28/26"  
[X Link](https://x.com/BioStocks/status/1978054266003632483) [@BioStocks](/creator/x/BioStocks) 2025-10-14T11:04Z 69.9K followers, 5094 engagements


"$LLY oral GLP-1 Orforglipron demonstrated superior glycemic control in two successful Phase X trials reconfirming its potential as a foundational treatment in type X diabetes. $VKTX"  
[X Link](https://x.com/BioStocks/status/1978412114155917339) [@BioStocks](/creator/x/BioStocks) 2025-10-15T10:46Z 69.9K followers, 10.4K engagements


"$IMAB Completes Enrollment in Phase 1b Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers. Topline data expected in Q1"  
[X Link](https://x.com/BioStocks/status/1954863429866377460) [@BioStocks](/creator/x/BioStocks) 2025-08-11T11:12Z 69.9K followers, 3759 engagements


"$VNDA Federal appeals court overturns FDA denial of Vanda's jet lag drug HETLIOZ"  
[X Link](https://x.com/BioStocks/status/1957410701087011252) [@BioStocks](/creator/x/BioStocks) 2025-08-18T11:54Z 69.9K followers, 15.8K engagements


"Bristol Myers Takeda to pool data for AI-based drug discovery. $BMY $TAK $RXRX $ABSI"  
[X Link](https://x.com/BioStocks/status/1973358455030518040) [@BioStocks](/creator/x/BioStocks) 2025-10-01T12:04Z 69.9K followers, 8066 engagements


"$AMGN announced the launch of AmgenNow a new direct-to-patient program starting with Repatha. Eligible Patients Can Access Repatha at Nearly XX% Discount from the List Price"  
[X Link](https://x.com/BioStocks/status/1975185190734500177) [@BioStocks](/creator/x/BioStocks) 2025-10-06T13:03Z 69.9K followers, 3742 engagements


"$GDRX And $AMGN Partner To Offer Repatha Nationwide For $239"  
[X Link](https://x.com/BioStocks/status/1975191726772883942) [@BioStocks](/creator/x/BioStocks) 2025-10-06T13:29Z 69.9K followers, 10.7K engagements


"$BIIB and Eisai Announce U.S. Availability of LEQEMBI IQLIK Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease"  
[X Link](https://x.com/BioStocks/status/1975298202976067786) [@BioStocks](/creator/x/BioStocks) 2025-10-06T20:32Z 69.9K followers, 4550 engagements


"$BMEA offering priced at $2.05"  
[X Link](https://x.com/BioStocks/status/1975542417668648964) [@BioStocks](/creator/x/BioStocks) 2025-10-07T12:43Z 69.9K followers, 4538 engagements


"$RCUS Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed XXXX Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase X EDGE-Gastric Study. $GILD"  
[X Link](https://x.com/BioStocks/status/1977506415422976294) [@BioStocks](/creator/x/BioStocks) 2025-10-12T22:47Z 69.9K followers, 14K engagements


"$CRVS initiated with an Overweight at Barclays. PT $16"  
[X Link](https://x.com/BioStocks/status/1977677628447535332) [@BioStocks](/creator/x/BioStocks) 2025-10-13T10:07Z 69.9K followers, 13.3K engagements


"$PGEN Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS. XX out of XX complete responders (83%) demonstrate continued complete response with median follow-up of XX months"  
[X Link](https://x.com/BioStocks/status/1977691664031310230) [@BioStocks](/creator/x/BioStocks) 2025-10-13T11:03Z 69.9K followers, 8265 engagements


"Oh man Talk about bad timing. 😬 $TVRD covg initiated with an Overweight at Barclays. PT $61"  
[X Link](https://x.com/BioStocks/status/1977729676563857649) [@BioStocks](/creator/x/BioStocks) 2025-10-13T13:34Z 69.9K followers, 10.8K engagements


"$DNLI Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) PDUFA extended from Jan X 2026 to April X 2026"  
[X Link](https://x.com/BioStocks/status/1977833297247187353) [@BioStocks](/creator/x/BioStocks) 2025-10-13T20:26Z 69.9K followers, 5829 engagements


"$BIIB LEQEMBI IQLIK Subcutaneous Autoinjector Named to TIMEs Best Inventions of 2025"  
[X Link](https://x.com/BioStocks/status/1977890086587928656) [@BioStocks](/creator/x/BioStocks) 2025-10-14T00:11Z 69.9K followers, 4082 engagements


"$BCRX $ATXS halted"  
[X Link](https://x.com/BioStocks/status/1978052566903615599) [@BioStocks](/creator/x/BioStocks) 2025-10-14T10:57Z 69.9K followers, 13.3K engagements


"$BCRX to acquire $ATXS for $XXXX in cash and XXXX shares of BioCryst common stock"  
[X Link](https://x.com/BioStocks/status/1978053749495988231) [@BioStocks](/creator/x/BioStocks) 2025-10-14T11:02Z 69.9K followers, 20.2K engagements


"$LLY In ACHIEVE-2 Orforglipron lowered A1C by up to XXX% compared to XXX% with dapagliflozin meeting the primary endpoint In ACHIEVE-5Orforglipron lowered A1C by an additional XXX% when taken with insulin glargine meeting the primary endpoint"  
[X Link](https://x.com/BioStocks/status/1978412309144867017) [@BioStocks](/creator/x/BioStocks) 2025-10-15T10:47Z 69.9K followers, 5909 engagements


"$ABSI to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on Dec XX. Announces Accelerated Initiation of Phase 1/2a Trial"  
[X Link](https://x.com/BioStocks/status/1978434376976228756) [@BioStocks](/creator/x/BioStocks) 2025-10-15T12:14Z 69.9K followers, 3982 engagements


"@oncinvestor @PersimmonTI"  
[X Link](https://x.com/BioStocks/status/1978601491414855878) [@BioStocks](/creator/x/BioStocks) 2025-10-15T23:18Z 69.9K followers, XXX engagements


"$CDTX initiated with an Overweight at Morgan Stanley. PT $190"  
[X Link](https://x.com/BioStocks/status/1978763387040317545) [@BioStocks](/creator/x/BioStocks) 2025-10-16T10:02Z 69.9K followers, 9907 engagements


"$NVO Halts Cell Therapy Work on Diabetes to Cut Costs Almost all of the division's about XXX employees are expected to be laid off"  
[X Link](https://x.com/BioStocks/status/1976742032090538285) [@BioStocks](/creator/x/BioStocks) 2025-10-10T20:10Z 69.9K followers, 6983 engagements


"$PTGX PT raised to $XX at Citi. $JNJ"  
[X Link](https://x.com/BioStocks/status/1979137048180047876) [@BioStocks](/creator/x/BioStocks) 2025-10-17T10:46Z 69.9K followers, 9660 engagements


"$LLY Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment. Two years of adjuvant Verzenio plus endocrine therapy (ET) reduced the risk of death by XXXX% versus ET alone"  
[X Link](https://x.com/BioStocks/status/1979158700397895725) [@BioStocks](/creator/x/BioStocks) 2025-10-17T12:12Z 69.9K followers, 4042 engagements


"$GMAB updated data from the Phase 1/2 RAINFOL-01 trial showed rinatabart sesutecan XXX mg/m2 demonstrated XX% confirmed ORR including two CRs regardless of FR expression. #ESMO25"  
[X Link](https://x.com/BioStocks/status/1979499006674747541) [@BioStocks](/creator/x/BioStocks) 2025-10-18T10:45Z 69.9K followers, 4357 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioStocks Avatar @BioStocks Bio Stocks™

Bio Stocks™ posts on X about $barcl, $lly, $nvo, $vktx the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXXXXXX -XX%
  • X Month XXXXXXX -XX%
  • X Months XXXXXXXXX +16%
  • X Year XXXXXXXXX +3.30%

Mentions: XX #

Mentions Line Chart

  • X Week XX -XXXX%
  • X Month XXX -XXXX%
  • X Months XXX +3.30%
  • X Year XXXXX +57%

Followers: XXXXXX #

Followers Line Chart

  • X Week XXXXXX +0.15%
  • X Month XXXXXX +0.77%
  • X Months XXXXXX +3.20%
  • X Year XXXXXX +5.40%

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #


Social category influence finance XXXX% stocks XXXX% cryptocurrencies XXXX%

Social topic influence $barcl #133, $lly #74, $nvo #69, $vktx 0.36%, $absi #4, $amgn 0.36%, $biib #3, $bcrx #7, $atxs #9, $anab XXXX%

Top accounts mentioned or mentioned by @biopharmiq @biotechtoast @dace0325 @thenorthstar5 @bambossie81 @pawcio2009 @a_may_md @grok @learnbiotech @_joebaffoe @biopharmacaster @persimmonti @yaireinhorn @canuckcapital5 @ikehiefosa @monaco_biotech @malibu_rum67 @bluemoontrades @mmikethe @oncinvestor

Top assets mentioned Eli Lilly and Company (LLY) Novo-Nordisk (NVO) Viking Therapeutics, Inc (VKTX) Amgen, Inc. (AMGN) Biogen Inc (BIIB) Roivant Sciences Ltd. Common Shares (ROIV) Passage (PASG) United Therapeutics, Corp. (UTHR) Sarepta Therapeutics, Inc. (SRPT) Cytokinetics Inc. (CYTK) Huma Finance (HUMA) Bitcoin (BTC) iShares BTC Trust (IBIT) Grayscale BTC ETF (GBTC) Deutsche Bank Aktiengesellschaft (DB) SPDR GOLD ETF (GLD) Apogee Therapeutics, Inc. Common Stock (APGE) Bristol-Myers Squibb Co (BMY) Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) GoodRx Holdings, Inc. Class A Common Stock (GDRX) Gilead Sciences, Inc. (GILD) Denali Therapeutics Inc. Common Stock (DNLI) Morgan Stanley (MS) Protagonist Therapeutics, Inc (PTGX) Johnson & Johnson (JNJ)

Top Social Posts #


Top posts by engagements in the last XX hours

"$ANAB Announces Late-Breaking Presentation of Complete Phase 2b Data for Rosnilimab in RA at #ACR25"
X Link @BioStocks 2025-10-13T13:17Z 69.9K followers, 3767 engagements

"$OMER and $NVO announce asset purchase and license agreement for Omeros clinical-stage MASP-3 inhibitor zaltenibart. $340M upfront"
X Link @BioStocks 2025-10-15T12:47Z 69.9K followers, 15K engagements

"$ROIV and Priovant Announce Positive Phase X VALOR Study Results for Brepocitinib in 52-Week Placebo-Controlled Trial in Dermatomyositis (DM)"
X Link @BioStocks 2025-09-17T11:01Z 69.9K followers, 9653 engagements

"$PASG 1-for-20 Reverse Split"
X Link @BioStocks 2025-07-10T11:02Z 69.9K followers, 3138 engagements

"$UTHR TETON-2 Pivotal Study of Tyvaso Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis"
X Link @BioStocks 2025-09-02T11:00Z 69.9K followers, 21.1K engagements

"$SRPT to Present New Data from its Neuromuscular Portfolio at #WMS25"
X Link @BioStocks 2025-10-03T12:31Z 69.9K followers, 8934 engagements

"$CYTK PT raised to $XX at Barclays"
X Link @BioStocks 2025-10-06T10:50Z 69.9K followers, 13.7K engagements

"$GUTS Announces Potent Preclinical Results from RJVA-002 a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity. RJVA-002 achieved XX% weight loss at five weeks in a translational obesity model; weight loss not yet plateaued"
X Link @BioStocks 2025-10-07T11:01Z 69.9K followers, 10.7K engagements

"$HUMA $60M direct offering priced at $2.11"
X Link @BioStocks 2025-10-07T13:05Z 69.9K followers, 4242 engagements

"Both #Bitcoin and Gold to likely feature on central bank balance sheets by 2030 - Deutsche Bank. $BTC $GLD $IBIT $GBTC"
X Link @BioStocks 2025-10-07T21:19Z 69.9K followers, 3705 engagements

"$APGE $300M offering priced @ $41/share"
X Link @BioStocks 2025-10-09T02:00Z 69.9K followers, 14.5K engagements

"$ABVX initiated with an Overweight at Barclays. PT $142"
X Link @BioStocks 2025-10-13T10:00Z 69.9K followers, 6749 engagements

"$RCKT FDA accepts BLA Resubmission of KRESLADI for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I) PDUFA 03/28/26"
X Link @BioStocks 2025-10-14T11:04Z 69.9K followers, 5094 engagements

"$LLY oral GLP-1 Orforglipron demonstrated superior glycemic control in two successful Phase X trials reconfirming its potential as a foundational treatment in type X diabetes. $VKTX"
X Link @BioStocks 2025-10-15T10:46Z 69.9K followers, 10.4K engagements

"$IMAB Completes Enrollment in Phase 1b Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers. Topline data expected in Q1"
X Link @BioStocks 2025-08-11T11:12Z 69.9K followers, 3759 engagements

"$VNDA Federal appeals court overturns FDA denial of Vanda's jet lag drug HETLIOZ"
X Link @BioStocks 2025-08-18T11:54Z 69.9K followers, 15.8K engagements

"Bristol Myers Takeda to pool data for AI-based drug discovery. $BMY $TAK $RXRX $ABSI"
X Link @BioStocks 2025-10-01T12:04Z 69.9K followers, 8066 engagements

"$AMGN announced the launch of AmgenNow a new direct-to-patient program starting with Repatha. Eligible Patients Can Access Repatha at Nearly XX% Discount from the List Price"
X Link @BioStocks 2025-10-06T13:03Z 69.9K followers, 3742 engagements

"$GDRX And $AMGN Partner To Offer Repatha Nationwide For $239"
X Link @BioStocks 2025-10-06T13:29Z 69.9K followers, 10.7K engagements

"$BIIB and Eisai Announce U.S. Availability of LEQEMBI IQLIK Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer's Disease"
X Link @BioStocks 2025-10-06T20:32Z 69.9K followers, 4550 engagements

"$BMEA offering priced at $2.05"
X Link @BioStocks 2025-10-07T12:43Z 69.9K followers, 4538 engagements

"$RCUS Anti-TIGIT Domvanalimab Plus Anti-PD-1 Zimberelimab and Chemotherapy Showed XXXX Months of Median Overall Survival as First-Line Treatment of Unresectable or Advanced Gastroesophageal Adenocarcinomas in the Phase X EDGE-Gastric Study. $GILD"
X Link @BioStocks 2025-10-12T22:47Z 69.9K followers, 14K engagements

"$CRVS initiated with an Overweight at Barclays. PT $16"
X Link @BioStocks 2025-10-13T10:07Z 69.9K followers, 13.3K engagements

"$PGEN Announces Long-Term Follow-Up Results Highlighting Ongoing Durable Complete Responses after Treatment with PAPZIMEOS. XX out of XX complete responders (83%) demonstrate continued complete response with median follow-up of XX months"
X Link @BioStocks 2025-10-13T11:03Z 69.9K followers, 8265 engagements

"Oh man Talk about bad timing. 😬 $TVRD covg initiated with an Overweight at Barclays. PT $61"
X Link @BioStocks 2025-10-13T13:34Z 69.9K followers, 10.8K engagements

"$DNLI Announces FDA Review Extension of BLA for Tividenofusp Alfa for the Treatment of MPS II (Hunter Syndrome) PDUFA extended from Jan X 2026 to April X 2026"
X Link @BioStocks 2025-10-13T20:26Z 69.9K followers, 5829 engagements

"$BIIB LEQEMBI IQLIK Subcutaneous Autoinjector Named to TIMEs Best Inventions of 2025"
X Link @BioStocks 2025-10-14T00:11Z 69.9K followers, 4082 engagements

"$BCRX $ATXS halted"
X Link @BioStocks 2025-10-14T10:57Z 69.9K followers, 13.3K engagements

"$BCRX to acquire $ATXS for $XXXX in cash and XXXX shares of BioCryst common stock"
X Link @BioStocks 2025-10-14T11:02Z 69.9K followers, 20.2K engagements

"$LLY In ACHIEVE-2 Orforglipron lowered A1C by up to XXX% compared to XXX% with dapagliflozin meeting the primary endpoint In ACHIEVE-5Orforglipron lowered A1C by an additional XXX% when taken with insulin glargine meeting the primary endpoint"
X Link @BioStocks 2025-10-15T10:47Z 69.9K followers, 5909 engagements

"$ABSI to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on Dec XX. Announces Accelerated Initiation of Phase 1/2a Trial"
X Link @BioStocks 2025-10-15T12:14Z 69.9K followers, 3982 engagements

"@oncinvestor @PersimmonTI"
X Link @BioStocks 2025-10-15T23:18Z 69.9K followers, XXX engagements

"$CDTX initiated with an Overweight at Morgan Stanley. PT $190"
X Link @BioStocks 2025-10-16T10:02Z 69.9K followers, 9907 engagements

"$NVO Halts Cell Therapy Work on Diabetes to Cut Costs Almost all of the division's about XXX employees are expected to be laid off"
X Link @BioStocks 2025-10-10T20:10Z 69.9K followers, 6983 engagements

"$PTGX PT raised to $XX at Citi. $JNJ"
X Link @BioStocks 2025-10-17T10:46Z 69.9K followers, 9660 engagements

"$LLY Verzenio (abemaciclib) prolonged survival in HR+ HER2- high-risk early breast cancer with two years of treatment. Two years of adjuvant Verzenio plus endocrine therapy (ET) reduced the risk of death by XXXX% versus ET alone"
X Link @BioStocks 2025-10-17T12:12Z 69.9K followers, 4042 engagements

"$GMAB updated data from the Phase 1/2 RAINFOL-01 trial showed rinatabart sesutecan XXX mg/m2 demonstrated XX% confirmed ORR including two CRs regardless of FR expression. #ESMO25"
X Link @BioStocks 2025-10-18T10:45Z 69.9K followers, 4357 engagements

@BioStocks
/creator/twitter::BioStocks